Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
JEC hearing: Members debate whether U.S. health care has become financial engineering as Medicare faces pressure
Loading...
Summary
At a Joint Economic Committee hearing, lawmakers and experts debated whether the U.S. has turned health care into ‘‘financial engineering,’’ focusing on Medicare solvency, obesity-related costs, fraud in ACA subsidies, and how market and statutory reforms might lower prices and improve prevention.
Chairman Schweickert opened a Joint Economic Committee hearing by arguing that the United States has turned health care into ‘‘financial engineering’’ and urged the panel to focus on what actually makes people healthier rather than only the financing arrangements. He cited a Joint Economic Committee Republican analysis that projects the Medicare trust fund could be exhausted within seven years and said rising health-care inflation will compound the demographic pressures on federal budgets.
Ranking Member Hassan framed the hearing around prevention, primary care and affordability, and introduced four witnesses: Brooks Tingle of John Hancock, Ed Clark of Banner Health, Ovik Roy of the Foundation for Research on Equal Opportunity, and Dr. Matthew Fiedler of the Brookings Institution.
Witnesses gave differing diagnoses and policy proposals. Tingle emphasized insurer-led prevention programs (John Hancock’s Vitality), reporting higher engagement and improved biometric measures among participants and noting John Hancock’s discounts for multi-cancer early detection tests. Clark described Banner Health’s integrated, risk-bearing approach and advocated premium‑based payments, team-based care and a Medicare Advantage demonstration to scale population-based models; he cited prior CMS partnerships that he said generated roughly $240 million in federal savings. Roy argued the tax treatment that excludes employer-sponsored insurance from taxable income is a primary driver of higher prices and pointed to Swiss-style individual portability and longer contracts as a model for greater fiscal sustainability. Fiedler laid out two broad strategies to reduce premiums—lower prices through competition or administrative pricing, and lower utilization through prevention and payment reform—and warned that underlying premium reductions are unlikely to blunt the immediate impact of the scheduled expiration of enhanced premium tax credits, which he said could render about 4 million people uninsured and raise average costs for marketplace enrollees.
Members questioned witnesses about program integrity in ACA exchanges after a Government Accountability Office (GAO) report. Witnesses recommended stronger identity and income verification processes and closer federal‑state coordination for enforcement. Committee members also pressed witnesses about hospital consolidation, site‑neutral payments, the role of pharmacy benefit managers (PBMs) and how new weight‑loss therapies (GLP‑1 class) priced at roughly $149/month could affect Medicaid and Medicare spending if adopted widely.
The hearing produced no formal votes. The committee adjourned after members and witnesses discussed a mix of near-term operational fixes (improved verification, employer transparency) and longer-term statutory changes (age band adjustments, reform of the tax exclusion for employer coverage, enabling longer-term insurance contracts).
The committee plans follow-up work and staff briefings were suggested; witnesses offered to provide more technical details through questions for the record.
